FDA Grants Profounda Orphan DD Approval for treatment of invasive candidiasis with Miltefosine
FDA Grants Profounda Orphan Drug Designation Approval for treatment of invasive candidiasis with Miltefosine - Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. and is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body. - In the United States, candidemia is one of the most common causes of bloodstream infections in hospitalized patients and it often results in long hospital stays and dea
